Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BA3071 |
Synonyms | |
Therapy Description |
BA3071 is a monoclonal antibody that targets CTLA4, potentially leading to enhanced antitumor immune response (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BA3071 | BA-3071|BA 3071 | CTLA4 Antibody 32 Immune Checkpoint Inhibitor 149 | BA3071 is a monoclonal antibody that targets CTLA4, potentially leading to enhanced antitumor immune response (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05180799 | Phase Ib/II | BA3071 + Nivolumab BA3071 | A Phase 1/2 Study of BA3071 | Recruiting | USA | AUS | 0 |